Global Market for Metabolomics is Projected to Reach US$1.4 Billion by the Year 2020
Increasing R&D Investments & Expanding
Applications to Fuel Growth in the Global Metabolomics Market, According to New
Report by Global Industry Analysts, Inc.
GIA announces
the release of a comprehensive global report on Metabolomics markets. Global market for Metabolomics is projected
to reach US$1.4 billion by the year 2020, driven by increasing
investments in Metabolomics research and rising adoption of the technology in
pharmaceutical and biotechnology sectors.
Metabolomics is
a dynamic concept and a newly emerging field of omic sciences. Metabolomics is
the study of chemical processes involving metabolites and provides information
on the chemical fingerprints of various cellular processes. Metabolomics or
metabolite profiling provides a more holistic view of the phenotype of
organelles, organs, tissues, cells and whole organisms, when compared to DNA,
RNA, or protein profile. With proteomic and genomic analysis proving inadequate
in offering comprehensive information, researchers are shifting focus onto metabolic
profiling to gain detailed insights into the cell’s physiology. Metabolomics
has evolved rapidly in recent years in- sync with advances in separation and
analysis technologies related to mass spectroscopy (MS) and nuclear magnetic
resonance (NMR) based detection techniques.
The market in
the coming years will be driven by the increasing volume of clinical trials,
rise in toxicological studies, growth of metabolomics data analysis solutions
and software, and increasing use of metabolomics as a diagnostic tool for
biomarker screening of various diseases. Adoption of metabolomics in drug
development will continue to encourage growth in the market. Technological
breakthroughs in analytical technologies and advances in data processing and
analysis software are expected to further boost growth prospects. Bioinformatics-based
metabolomics applications will witness robust growth in pharmaceutical
research, clinical research, food and beverage analysis, plant and animal
phenotyping, nutrition research, environmental science and biofuel development.
With small molecule metabolite profiling offering a deeper understanding of
disease mechanism than genetic or protein profiling, metabolomics has become
the current spotlight for pharmaceutical and biotech companies. Biomarkers have
set the stage for the introduction of personalized medicines that reduce side
effects and improve patient outcome.
As stated by
the new market research report on Metabolomics, the United States represents
the largest market worldwide. The presence of a sophisticated healthcare
infrastructure conducive to pharmaceutical R&D is a key factor supporting
the country’s dominance. Asia-Pacific ranks as the fastest growing market with
a CAGR of 18.4% over the analysis period. Aging population, increase in
age-related chronic illnesses, improving healthcare infrastructure, growing
number of pharmaceutical and biotech companies, rising demand for improved
pharmaceutical products, and increased investments in life science research are
factors driving growth in the region.
Major players covered
in the report include AB SCIEX, Agilent Technologies Inc., Biocrates Life Sciences
AG, Bio-Rad Laboratories Inc., Bruker Corporation, Chenomx Inc., Human
Metabolome Technologies Inc., LECO Corporation, Metabolon Inc., Metanomics
GmbH, Shimadzu Corporation, SiDMAP LLC, Thermo Fisher Scientific Inc., and
Waters Corporation, among others.
The research
report titled “Metabolomics: A Global Strategic Business
Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market
trends, issues, drivers, mergers, acquisitions and other strategic industry
activities of global companies. The report provides market estimates and
projections in US dollars for all major geographic markets including the US,
Canada, Japan, Europe (France, Germany, Italy, UK, and Rest of Europe),
Asia-Pacific, Latin America, and Rest of World. The report analyzes the global
Metabolomics market by segments such as Bioinformatics Tools in Metabolomic
Research, Bioanalytical Instruments and Equipment, and Metabolomics
Applications.
Comments
Post a Comment